122 related articles for article (PubMed ID: 10918192)
1. Allelic losses demonstrate monoclonality of multifocal bladder tumors.
Louhelainen J; Wijkström H; Hemminki K
Int J Cancer; 2000 Aug; 87(4):522-7. PubMed ID: 10918192
[TBL] [Abstract][Full Text] [Related]
2. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
3. [Clonality analysis of multifocal bladder tumors].
Zhang SB; Zhang YP; Liu LN; Zhang YN; Huang SF; Cheng L
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):5-6. PubMed ID: 17374229
[No Abstract] [Full Text] [Related]
4. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
[TBL] [Abstract][Full Text] [Related]
6. Allelotype of human bladder cancer.
Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
[TBL] [Abstract][Full Text] [Related]
7. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer.
Chow NH; Cairns P; Eisenberger CF; Schoenberg MP; Taylor DC; Epstein JI; Sidransky D
Int J Cancer; 2000 Nov; 89(6):514-8. PubMed ID: 11102896
[TBL] [Abstract][Full Text] [Related]
8. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder.
Cheng L; MacLennan GT; Zhang S; Wang M; Pan CX; Koch MO
Cancer; 2004 Jul; 101(1):183-8. PubMed ID: 15222005
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue.
Berger AP; Parson W; Stenzl A; Steiner H; Bartsch G; Klocker H
Eur Urol; 2002 May; 41(5):532-9. PubMed ID: 12074795
[TBL] [Abstract][Full Text] [Related]
10. Molecular clonal analysis of recurrent bladder cancer.
Junker K; Wolf M; Schubert J
Oncol Rep; 2005 Aug; 14(2):319-23. PubMed ID: 16012709
[TBL] [Abstract][Full Text] [Related]
11. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder.
Li M; Zhang ZF; Reuter VE; Cordon-Cardo C
Am J Pathol; 1996 Jul; 149(1):229-35. PubMed ID: 8686747
[TBL] [Abstract][Full Text] [Related]
13. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
[TBL] [Abstract][Full Text] [Related]
14. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
15. Allelic changes at multiple regions of chromosome 5 are associated with progression of urinary bladder cancer.
von Knobloch R; Bugert P; Jauch A; Kälble T; Kovacs G
J Pathol; 2000 Feb; 190(2):163-8. PubMed ID: 10657014
[TBL] [Abstract][Full Text] [Related]
16. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
17. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
18. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity analysis on chromosome 5p defines 5p13-12 as the critical region involved in tumor progression of bladder carcinomas.
Böhm M; Kleine-Besten R; Wieland I
Int J Cancer; 2000 Mar; 89(2):194-7. PubMed ID: 10754499
[TBL] [Abstract][Full Text] [Related]
20. Molecular serological diagnosis in transitional cell bladder cancer.
von Knobloch R; Brandt H; Hofmann R
Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]